Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2011
06/22/2011EP2334685A2 Amorphous pemetrexed disodium
06/22/2011EP2334684A1 Pyrazolopyrimidines and their use for the treatment of cns disorders
06/22/2011EP2334683A1 Saturated bicyclic heterocyclic derivatives as smo antagonists
06/22/2011EP2334682A1 Pyrrolo [ 1, 2 -b] pyridazine derivatives and their use as hif modulators
06/22/2011EP2334681A1 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors
06/22/2011EP2334675A1 Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
06/22/2011EP2334301A1 Macrocyclics pyrimidines as aurora kinase inhibitors
06/22/2011EP2231662B1 8-anilinoimidazopyridines and their use as anti-cancer and/or anti-inflammatory agents
06/22/2011EP2102157B1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
06/22/2011EP1812004B1 Ortho- condensed pyridine and pyrimidine derivatives (e. g. purines) as protein kinases inhibitors
06/22/2011CN1898244B Triazole derivatives as vasopressin antagonists
06/22/2011CN1809570B [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof
06/22/2011CN1701073B Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
06/22/2011CN102105448A Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states
06/22/2011CN101560206B Intermediate of pemetrexed disodium, preparation method thereof and method for preparing pemetrexed disodium thereby
06/22/2011CN101463048B Ruthenium complex inducing DNA conformation transition and preparation thereof
06/22/2011CN101175758B Anhydrous crystalline forms of n-[1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
06/22/2011CN101157591B Method for nitryl rduction to produce amido in compound containing nitryl phenyl
06/22/2011CN101031569B Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
06/21/2011USRE42477 Carboxylic acid derivatives, their preparation and use
06/21/2011US7964722 Light-driven rotary molecular motors
06/21/2011US7964720 Method of making porphyrins
06/21/2011US7964607 Pyrazolo[3,4-d]pyrimidine compounds
06/21/2011US7964600 Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
06/21/2011US7964598 ApoE4 domain interaction inhibitors and methods of use thereof
06/21/2011US7964399 Nucleotide sequence vector that encodes a truncated Flk-1 protein which inhibits the binding of VEGF; uses for evaluate and screen of cancer drugs; as biodrug for modulating vasculogenesis and angiogenesis, inhibiting the tumor growth
06/21/2011CA2646962C Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/21/2011CA2618682C Viral polymerase inhibitors
06/21/2011CA2591314C Novel pyrrolo[3,2-d]pyrimidin-4-one derivatives and their use in therapy
06/21/2011CA2527155C Cationic porphyrin derivatives and uses thereof
06/18/2011CA2724086A1 Pharmaceutical compounds
06/16/2011WO2011071840A1 Inhibitors of diacylglycerol acyltransferase
06/16/2011WO2011071758A1 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands
06/16/2011WO2011071725A1 Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core
06/16/2011WO2011071716A1 Heterocyclic compounds containing an indole core
06/16/2011WO2011071255A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
06/16/2011WO2011071136A1 Therapeutic agent for fibromyalgia
06/16/2011WO2011071057A1 Pharmaceutical composition for treatment or prevention of alzheimer's disease containing sulfur-containing heterocyclic derivative
06/16/2011WO2011047770A3 Pyrazolopyrimidine derivatives
06/16/2011WO2011042107A3 Materials for organic electroluminescent devices
06/16/2011US20110144335 Pentasil-structure zeolithic material the production and use thereof
06/16/2011US20110144325 Methods and intermediates for the synthesis of porphyrins
06/16/2011US20110144324 Methods and compositions comprising macrocycles
06/16/2011US20110144177 Carbamoyl Esters That Inhibit Cholinesterase And Release Pharmacologically Active Agents
06/16/2011US20110144135 Compounds for Modulating TRPV3 Function
06/16/2011US20110144134 Anti-Inflammatory Pyrazolopyrimndines
06/16/2011US20110144131 Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines
06/16/2011US20110144113 Triazolotriazines as kinase inhibitors
06/16/2011US20110144092 Substituted alkyl pyrimidin-4-one derivatives
06/16/2011US20110144091 Inhibitors of Diacylglycerol Acyltransferase
06/16/2011US20110144084 6 substituted 2- heterocyclylamino pyrazine compounds as chk-1 inhibitors
06/16/2011US20110143925 Catalysts and methods for catalytic oxidation
06/16/2011US20110142856 Compound containing basic group and use thereof
06/16/2011US20110142796 Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inhibitors
06/16/2011US20110142757 Novel compounds and their uses in diagnosis
06/16/2011US20110140092 Charge transport compositions and electronic devices made with such compositions
06/16/2011CA2783684A1 Inhibitors of diacylglycerol acyltransferase
06/16/2011CA2782409A1 3,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetylcholine receptor ligands
06/15/2011EP2333004A1 Soluble terminally modified imide oligomer using 2-phenyl-4,4'-diaminodiphenyl ether, varnish, cured product thereof, imide prepreg thereof, and fiber-reinforced laminate having excellent heat resistance
06/15/2011EP2332963A2 Process for preparing macrocyclic compounds
06/15/2011EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation
06/15/2011EP2332648A1 Catalyst for degrading lignin, catalyst for degrading aromatic hydrocarbon, and porphyrin
06/15/2011EP2331571A1 Nmda receptor modulators and uses thereof
06/15/2011EP2331547A1 Pyrrolopyrimidine compounds as cdk inhibitors
06/15/2011EP2331546A1 2-alkyl-6-cycloamino-3-(pyridin-4-yl)imidazo[1,2-ib]-pyridazine derivatives, preparation thereof, and therapeutic application thereof
06/15/2011EP2331545A2 Improved process for preparation of (2r)-4-oxo-4-[3- (trifluoromethyl)-5,6-dihydro [1,2,4]-triazolo[4,3-a]pyrazin- 7(8h)-yl]-l-(2,4,5-trifluorophenyl)butan-2-amine&new impurities in preparation thereof
06/15/2011EP2331544A1 2-amino pyrimidine compounds as potent hsp-90 inhibitors
06/15/2011EP2185561B1 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo(1,2-a)-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof
06/15/2011EP1899346B1 Pyrrolotriazine compounds useful as kinase inhibitors
06/15/2011EP1851225B1 Pyrazolo-pyrimidine derivatives as mglur2 antagonists
06/15/2011EP1838718B1 Pyrrolopyrazoles, potent kinase inhibitors
06/15/2011EP1622616B1 Inhibitors of akt activity
06/15/2011EP1578751B1 Pyrrolopyrimidine derivatives
06/15/2011CN1930145B Cycloalkanopyridine derivative
06/15/2011CN102099359A Hepatitis c virus inhibitors
06/15/2011CN102099357A Carboxamide compounds for the treatment of metabolic disorders
06/15/2011CN102099351A 3-heterocyclic substituted indole derivatives and methods of use thereof
06/15/2011CN102099340A Heterocyclic compounds as factor IXA inhibitors
06/15/2011CN102093751A Pigment particle dispersion body, photo-curing composition and color filter using dispersion
06/15/2011CN102093369A Method for extracting chlorophyll and preparing sodium ferrous chlorophyll from silkworm excrement
06/15/2011CN102093368A Preparation method of chlorophyll ketonic acid salt
06/15/2011CN102093367A Preparation method of spiro quaternary ammonium salt for organic electrolyte of super capacitor
06/15/2011CN102093366A Bicyclo-amino pyrazol compound and application of bicycle-amino pyrazol compound in resisting coxsackie virus
06/15/2011CN102093365A Method for producing 4-hydroxy-6-methyl-1,3,3a,7-tetraazaindene
06/15/2011CN102093364A 2,4-diamido-6,7-dihydro-5H-pyrrolo [2,3] pyrimidine derivative as focal adhesion kinase/pyruvate kinase 2 (FAK/Pyk2) inhibitor
06/15/2011CN102093363A Pyrrolo-triazine aniline compounds useful as kinase inhibitors
06/15/2011CN102093245A Preparation method of sitagliptin intermediate, sitagliptin or salts thereof
06/15/2011CN101817825B Bi-dihydroxy ethylene urea, derivatives, preparation method and application thereof
06/15/2011CN101596191B Method for treatment of disease using malonyl-coa decarboxylase inhibitor
06/15/2011CN101550140B Method and apparatus for synthesis of tetaraary porphyrin
06/15/2011CN101418002B Conjugated dendritic electrically-induced pure red material and preparation method and use thereof
06/15/2011CN101124228B Pyrazolopyrimidine compounds as antitumor agents
06/15/2011CN101072778B Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy
06/14/2011USRE42462 Carboxylic acid derivatives, their preparation and use
06/14/2011US7960725 Aryl-aryl dendrimers
06/14/2011US7960560 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione
06/14/2011US7960409 e.g. 4-(3-fluorophenyl)-7-({4-[1-hydroxy-1-(trifluoromethyl)propyl]-1H-1,2,3-triazol-1-yl}methyl)-2H-chromen-2-one; leukotriene biosynthesis and 5-lipoxygenase (5-LO); inhibitor; antiatherosclerotic, antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents
06/14/2011US7960407 Crystal forms of an imidazole derivative
06/14/2011US7960400 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
06/14/2011US7960398 Potent inhibitors of TNF activity